Ranganath ( In the central nervous system, proglucagon and proglucagon-derived peptides (GLP-1, glucagon-like peptide-2, GLP-2, and oxyntomodulin, OXM) are only present in a small group of neurons in the nucleus tractus solitarius ( In addition, the GLP-1 can inhibit postprandial gastric emptying and reduce gastric acid secretion, inhibit gastric and duodenal peristalsis by inhibiting vagus nerve, and increase the pressure of pylorus, thus reducing appetite, causing a reduction in body weight and participating in the so-called ileal braking effect ( 3 Experimental evidence of GLP-1R agonists GLP-1R agonists can be divided into short-acting and long-acting preparations according to the time-effect and the volume of injections
Despite the contradictory data regarding kidney outcomes, two surrogate outcomes benefit the most from combined therapy: the decline in eGFR slope and the reduction in urinary albumin-to-creatinine ratio
It may therefore be concluded that, as glucose-lowering therapy, semaglutide (both s.c
Yi B, Hu X, Wen Z, Zhang T, Cai Y
It is not FDA-approved and may vary in quality, safety, and effectiveness from commercially available medications like Ozempic or Wegovy